Biologics License Application (BLA) Submission to U.S. FDA for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Anticipated in 1H 2026 Spruce to Host Conference Call Today at 8:30 a.m. ET "This ...
Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former BioMarin rare disease candidate that it plans to file for a speedy approval ...
Property technology provider Spruce launched SprucePowered, a white-label title and closing services solution that gives proptech companies the ability to form their own title agencies and control the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results